How people are exposed to neighborhoods racially different from their own.

How people are exposed to neighborhoods racially different from their own.

Publication date: Jul 09, 2024

In US cities, neighborhoods have long been racially segregated. However, people do not spend all their time in their neighborhoods, and the consequences of residential segregation may be tempered by the contact people have with other racial groups as they traverse the city daily. We examine the extent to which people’s regular travel throughout the city is to places “beyond their comfort zone” (BCZ), i. e., to neighborhoods of racial composition different from their own-and why. Based on travel patterns observed in more than 7. 2 million devices in the 100 largest US cities, we find that the average trip is to a neighborhood less than half as racially different from the home neighborhood as it could have been given the city. Travel to grocery stores is least likely to be BCZ; travel to gyms and parks, most likely; however, differences are greatest across cities. For the first ~10 km people travel from home, neighborhoods become increasingly more BCZ for every km traveled; beyond that point, whether neighborhoods do so depends strongly on the city. Patterns are substantively similar before and after COVID-19. Our findings suggest that policies encouraging more 15-min travel-that is, to amenities closer to the home-may inadvertently discourage BCZ movement. In addition, promoting use of certain “third places” such as restaurants, bars, and gyms, may help temper the effects of residential segregation, though how much it might do so depends on city-specific conditions.

Open Access PDF

Concepts Keywords
Daily cell-phone data
Grocery Cities
Gyms COVID-19
Parks diversity
Racial everyday mobility
Humans
Neighborhood Characteristics
Racial Groups
racial segregation
Residence Characteristics
SARS-CoV-2
Social Segregation
third places
Travel
United States

Semantics

Type Source Name
disease VO time
disease MESH COVID-19
disease IDO cell
drug DRUGBANK Aspartame
drug DRUGBANK Polyethylene glycol
disease VO monthly
disease VO device
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Sodium lauryl sulfate
disease VO population
drug DRUGBANK Coenzyme M
disease VO company
drug DRUGBANK Isoxaflutole
disease IDO algorithm
disease VO frequency
disease IDO host
drug DRUGBANK Carboxyamidotriazole
disease MESH lifestyles

Original Article

(Visited 2 times, 1 visits today)